Skip to main content
Equibles

Trexquant Investment LP

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1633445 STAMFORD, CT
Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,045,104
+$380,218 QoQ
Shares Held
298,174
+10.4% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#58
of 330 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $612,941,942 across 144 Biotechnology names. NTLA ranks #34 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 505,160 $35,376,354
2 TWST
Twist Bioscience Corp
 255,271 $26,262,280
3 REGN
Regeneron Pharmaceuticals, Inc.
 41,839 $26,088,290
4 RVMD
Revolution Medicines, Inc.
 120,122 $22,496,448
5 AXSM
Axsome Therapeutics, Inc.
 83,679 $20,482,108
6 RARE
Ultragenyx Pharmaceutical Inc.
 556,385 $18,577,695
7 INSM
INSMED Inc
 156,553 $16,691,680
8 SRRK
Scholar Rock Holding Corp
 275,712 $15,164,160

All Filings in NTLA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,045,104 298,174
2025-09-30 $4,664,886 270,115
2025-06-30 $10,574,364 1,127,331
2025-03-31 $4,299,388 604,696
2024-12-31 $7,784,589 667,632
2024-06-30 $3,823,130 170,828
2022-09-30 $1,485,793 26,551
2021-09-30 $1,555,603 11,596
2021-03-31 $1,002,625 12,493
2020-09-30 $889,689 44,753
2020-06-30 $733,219 34,882
2020-03-31 $311,877 25,501